Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1993 1
2001 1
2008 2
2009 1
2015 1
2016 1
2017 2
2018 1
2019 4
2020 5
2021 4
2022 4
2023 5
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma.
Chanda T, Hauser K, Hobelsberger S, Bucher TC, Garcia CN, Wies C, Kittler H, Tschandl P, Navarrete-Dechent C, Podlipnik S, Chousakos E, Crnaric I, Majstorovic J, Alhajwan L, Foreman T, Peternel S, Sarap S, Özdemir İ, Barnhill RL, Llamas-Velasco M, Poch G, Korsing S, Sondermann W, Gellrich FF, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Goebeler M, Schilling B, Utikal JS, Ghoreschi K, Fröhling S, Krieghoff-Henning E; Reader Study Consortium; Brinker TJ. Chanda T, et al. Nat Commun. 2024 Jan 15;15(1):524. doi: 10.1038/s41467-023-43095-4. Nat Commun. 2024. PMID: 38225244 Free PMC article.
[Adjuvant and neoadjuvant therapy of melanoma].
Debus D, Hauschild A, Schultz ES. Debus D, et al. Dtsch Med Wochenschr. 2025 May;150(10):555-561. doi: 10.1055/a-2453-8887. Epub 2025 Apr 22. Dtsch Med Wochenschr. 2025. PMID: 40262754 Review. German.
[Malignant melanoma - from diagnosis to follow-up care].
Krieter M, Schultz E, Debus D. Krieter M, et al. Among authors: debus d. MMW Fortschr Med. 2019 May;161(10):42-50. doi: 10.1007/s15006-019-0018-6. MMW Fortschr Med. 2019. PMID: 31129855 Review. German. No abstract available.
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.
Leven AS, Peters T, Rajcsanyi LS, Weichenthal M, Mohr P, Meier F, von Wasielewski I, Gutzmer R, Utikal J, Terheyden P, Herbst R, Haferkamp S, Pföhler C, Leiter U, Forschner A, Kreuter A, Gebhardt C, Lutze S, Weishaupt C, Grabbe S, Debus D, Hassel J, Welzel J, Heinzerling L, Berking C, Loquai C, Gambichler T, Ziemer M, Becker JC, Tasdogan A, Zimmer L, Livingstone E, Schadendorf D, Roesch A, Hinney A, Ugurel S. Leven AS, et al. Among authors: debus d. Eur J Cancer. 2025 Sep 9;227:115668. doi: 10.1016/j.ejca.2025.115668. Epub 2025 Jul 29. Eur J Cancer. 2025. PMID: 40749417 Free article.
Intermittent vemurafenib therapy in malignant melanoma.
Treiber N, Huber MA, Schneider LA, Scharffetter-Kochanek K, Schultz E, Debus D. Treiber N, et al. Among authors: debus d. J Dtsch Dermatol Ges. 2017 Apr;15(4):451-454. doi: 10.1111/ddg.13034. Epub 2017 Mar 15. J Dtsch Dermatol Ges. 2017. PMID: 28294514 No abstract available.
Intervalltherapie mit Vemurafenib beim malignen Melanom.
Treiber N, Huber MA, Schneider LA, Scharffetter-Kochanek K, Schultz E, Debus D. Treiber N, et al. Among authors: debus d. J Dtsch Dermatol Ges. 2017 Apr;15(4):450-453. doi: 10.1111/ddg.13034_g. J Dtsch Dermatol Ges. 2017. PMID: 28378474 No abstract available.
34 results